Related Experiment Video
Updated: Dec 10, 2025
Nitrogen Compound Characterization in Fuels by Multidimensional Gas Chromatography
Published on: May 15, 2020
Potential Significant Changes in Nuclear Regulatory Commission Policies Regarding Training and Experience
Paul E Wallner1, Ralph P Lieto2, Gary L Dillehay3
121st Century Oncology, Moorestown, New Jersey; Chair, Work Group of the ACR Commission on Government Relations, Federal Regulatory Committee; Chair, Physicians Consortium for Performance Improvement, Oncology Technical Expert Panel.
Abstract:
The Code of Federal Regulations is a single-source repository of all rules and regulations promulgated by federal departments and agencies. In Title 10, Chapter 1, Part 35, Subpart D, §§35.100 to 35.290 detail regulations for the use of unsealed by product material not requiring a written directive (ie, diagnostic radiopharmaceuticals), and in Subpart E, §§35.300 to 35.396 detail regulations for the use of unsealed by product material requiring a written directive (ie, therapeutic radionuclides). Currently proposed changes for both Subparts D and E could have profound effects on patient care, public safety, and the practice of nuclear medicine, diagnostic radiology, and radiation oncology. This article details those proposed changes and actions under way to prevent promulgation of proposals that could negatively affect patient care and public safety.
